Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Apr. 30, 2017
Oct. 31, 2016
Current assets:    
Cash and cash equivalents $ 2,876,897 $ 2,488,323
Short-term investments in certificates of deposit 2,250,000 750,000
Prepaid expenses and other current assets 64,647 162,069
Total current assets 5,191,544 3,400,392
Patents, net of accumulated amortization of $1,127,688 and $965,040, respectively 1,908,423 2,071,071
Property and equipment, net of accumulated depreciation of $68,228 and $46,950, respectively 149,487 156,644
Total assets 7,249,454 5,628,107
Current liabilities:    
Accounts payable and accrued expenses 660,023 468,756
Secured debenture (Note 7) 3,000,000
Total current liabilities 3,660,023 468,756
Patent acquisition obligation 4,171,876
Total liabilities 3,660,023 4,640,632
Commitments and contingencies (Note 11)
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; -0- and 140 shares issued and outstanding, respectively 14,000
Common stock, par value $.01 per share; 24,000,000 shares authorized; 11,694,863 and 8,752,387 shares issued and outstanding, respectively 116,949 87,524
Additional paid-in capital 156,066,446 152,051,144
Accumulated deficit (152,593,964) (151,165,193)
Total shareholders’ equity 3,589,431 987,475
Total liabilities and shareholders’ equity 7,249,454 5,628,107
Series A Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; -0- and 140 shares issued and outstanding, respectively 14,000
Preferred Stock [Member]    
Shareholders’ equity:    
Preferred stock, par value $100 per share; 19,860 shares authorized; no shares issued or outstanding and Series A convertible preferred stock, par value $100 per share; 140 shares authorized; -0- and 140 shares issued and outstanding, respectively